Response to sumatriptan in headache of MELAS syndrome

Neurology

Volumn 61, Issue 4, 2003, Pages 577-578

  Iizuka, Takahiro ^a   Sakai, Fumihiko ^b   Endo, Motoi ^b   Suzuki, Norihiro ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; HEADACHE; HUMAN; MELAS SYNDROME; MIGRAINE; PRIORITY JOURNAL; RATING SCALE;

EID: 0042932706     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000078931.87815.B3     Document Type: Article

References (7)

1. Pavlakis SG, Phillips PC, Dimauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488.
2. Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002;59:816-824.
3. Iizuka T, Tsukahara S, Takiyama Y, Suzuki N, Sakai F. Slowly progressive migration of cortical laminar necrosis. MRI characteristics for MELAS syndrome. Neurology 2001;56(suppl 3)A229. Abstract.
4. Tomita M, Suzuki N, Igarashi H, Endo M, Sakai F. Evidence against strong correlation between chest symptoms and ischemic coronary changes after subcutaneous sumatriptan injection. Intern Med 2002;41:622-625.
5. Goadsby PJ, Edvinsson L. Sumatriptan reverses the changes in calcitonin gene-related peptide seen in the headache phase of migraine. Cephalalgia 1991;11(suppl 11):3-4.
6. Cutrer FM, Schoenfeld D, Limmroth V, Panahian N, Moskowitz MA. Suppression by the sumatriptan analogue, CP-122, 288 of c-fos immuno-reactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 1995;114:987-992.
7. Leira EC, Cruz-Flores S, Leacock RO, Abdulrauf SI. Sumatriptan can alleviate headaches due to carotid artery dissection. Headache 2001;41:590-591.